Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Ozempic, Wegovy Weight-Loss Drugmaker On Long-Term Effects
Posted
June 8, 2024
Views
6,529
Likes
54
Comments
8
Engagement
June 8, 2024
6,529
54
8
0.95%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:22Now Playing#Ozempic #Wegovy #obesity #diabetes #weightloss #healthcare #pharmaceuticals #novonordisk #drugs #leadership #CEO
Novo Nordisk’s blockbuster diabetes and obesity drugs, Ozempic and Wegovy, are revolutionizing the weight loss industry. Both contain the key ingredient, semaglutide - generating billions in sales. In some cases, patients might need to take the drugs indefinitely to avoid regaining much of the weight they lost. Speaking on Bloomberg’s Leaders With Lacqua, Novo Nordisk CEO Lars Fruergaard Jørgensen gives his personal views on the prospects of lifelong treatment and why the company will need to build a portfolio of interventions.
Watch the full interview
#bloomberg #leaderswithlacqua #francinelacqua
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, uptotheminute market data, features, profiles and more.
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Bloomberg Radio
Bloomberg Surveillance
Bloomberg Politics
Bloomberg Originals
Watch more on YouTube:
Bloomberg Technology
Bloomberg Originals
Bloomberg Quicktake
Bloomberg Espanol
Bloomberg Podcasts
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
